Abstract
This systematic review and meta-analysis examined the association between race and ethnicity and fracture risk in the United States. We identified relevant studies by searching PubMed and EMBASE for studies published from the databases’ inception date to December 23, 2022. Only observational studies conducted in the US population that reported the effect size of racial-ethnic minority groups versus white people were included. Two investigators independently conducted literature searches, study selection, risk of bias assessment, and data abstraction; discrepancies were resolved by consensus or consultation of a third investigator. Twenty-five studies met the inclusion criteria, and the random-effects model was used to calculate the pooled effect size due to heterogeneity between the studies. Using white people as the reference group, we found that people of other races and ethnic groups had a significantly lower fracture risk. In Black people, the pooled relative risk (RR) was 0.46 (95% confidence interval (CI), 0.43–0.48, p < 0.0001). In Hispanics, the pooled RR was 0.66 (95% CI, 0.55–0.79, p < 0.0001). In Asian Americans, the pooled RR was 0.55 (95% CI, 0.45–0.66, p < 0.0001). In American Indians, the pooled RR was 0.80 (95% CI, 0.41–1.58, p = 0.3436). Subgroup analysis by sex in Black people revealed the strength of association was greater in men (RR = 0.57, 95% CI = 0.51–0.63, p < 0.0001) than in women (RR = 0.43, 95% CI = 0.39–0.47, p < 0.0001). Our findings suggest that people of other races and ethnic groups have a lower fracture risk than white people.
Similar content being viewed by others
Introduction
As the population in the United States ages, osteoporotic fractures are becoming an increasing public health concern1. By 2025, the annual economic burden of osteoporotic fractures is expected to exceed $25 billion, and its annual aggregate incidence is expected to surpass 3 million2. In recent years, the prevalence of osteoporosis among US adults aged 50 and over was 12.6%, and the prevalence of osteopenia, which can often progress to osteoporosis, was 43.1%3. These affected populations, which constitute a major proportion of the US population, are especially vulnerable to osteoporotic fractures. Patients discharged after suffering such fractures are still at an increased risk of subsequent fractures, morbidity, and mortality4,5,6.
These fracture rates and related mortality vary by race and ethnicity7,8. In white men and women, the incidence of hip fractures has decreased since 20009,10. However, a similar decrease was not observed in Black people, Asian Americans, Hispanics, and American Indians9,10. Such difference could be due to health disparities existing across these groups with regard to osteoporosis awareness, in addition to disparities in osteoporosis screening, diagnosis, and treatment11,12,13. Given the current trends in demographic changes, populations from racial-ethnic minority groups are expected to compose a majority of the population growth in the following decades14. Understanding the association between race and ethnicity and fracture risk is vital in preventing fracture and decreasing the burden on racial and ethnic minorities and the healthcare system.
Recent literature has questioned the use of race and ethnicity in medicine, especially in the context of clinical algorithms, whose outputs are adjusted based on a patient’s race or ethnicity15,16,17. Often, these adjustments tend to underestimate the needs of minority patients, which may delay necessary interventions and further exacerbate racial disparities in medical care16,17. In the setting of osteoporosis, extensive research into the relationship between race and ethnicity and fracture risk has been scarce. Previous literature reviews addressing the issue have demonstrated that race and ethnicity do play a role in the risk of fracture in minority groups18,19. However, such reviews did not provide quantitative evidence about the association between race and ethnicity and the risk of fractures. These reviews were published over a decade ago and were not able to include recent reports20,21,22,23,24. To our knowledge, there have not been any systematic reviews or meta-analyses conducted on this subject. In light of these considerations, this study aimed to quantitatively assess all available studies to investigate the association between race and ethnicity and the risk of fractures, which is vital to promoting race-based methodologies for effective osteoporosis prevention and treatment.
Results
Literature search
From the initial literature search, we identified 6971 articles, as well as an additional 5 through searching references of potentially relevant articles (Fig. 1). After removing duplicates, 5882 articles were screened through their titles and abstracts, and 68 full-text articles were retrieved and assessed for eligibility. At this initial screening stage, the inter-rater agreement was fair (κ = 0.32). From these, 25 articles met the inclusion criteria10,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43. However, two studies were conducted by the same research team and used the same data source but reported different outcomes33,34. These two studies were combined, and a final twenty-four studies were included in our meta-analysis. At this second stage, the inter-rater agreement was substantial (κ = 0.70).
Study characteristics
The study characteristics of the twenty-four included studies are summarized in Table 1, which included a total of 7,234,903 participants. Of these twenty-four studies, one was case-control in design, four were cross-sectional, and nineteen were cohort. The majority of the studies (13/24) included participants ≥ 65 years, with the range of inclusion age being ≥ 17 to ≥ 70 years. Twenty-two studies reported fracture risk for Black people, eleven for Hispanics, nine for Asian Americans, and six for American Indians. Eleven studies reported strictly hip fractures as the outcome, 3 reported strictly vertebral fractures as the outcome, and ten reported various fractures as the outcome. With regards to the variables adjusted, three did not adjust for any variables, eight adjusted solely for age, and thirteen adjusted for age and other variables.
Meta-analysis
The RRs of fracture risk in different races and ethnic groups are presented in Fig 2. Black people, Hispanics, Asian Americans, and American Indians have significantly lower fracture risk when compared to white people. The relative risk of fracture in Black people was 0.46 (95% CI, 0.43–0.48, p < 0.0001). The relative risk of fracture was 0.66 (95% CI, 0.55–0.79, p <0.0001) in Hispanics, 0.55 (95% CI, 0.45–0.66, p <0.0001) in Asian Americans, and 0.80 (95% CI, 0.41–1.58, p = 0.3436) in American Indians.
When different exclusion criteria were applied to the studies, with the exception of American Indians, the association between race and fracture risk changed slightly but remained significant. After applying various criteria, the RR ranged from 0.44 to 0.46 in Black people (Table 2). In studies investigating fracture risk in Hispanics, applying different exclusion criteria led to RR varying from 0.63 to 0.74 (Table 3). In studies that reported fracture risk in Asian Americans, the exclusion of studies according to different criteria resulted in RR ranging from 0.50 to 0.66 (Table 4). In American Indian studies, including studies that reported osteoporotic fractures only decreased the RR to 0.72. When other exclusion criteria were applied, the RR increased to the range of 1.02 to 1.10 (Table 5). However, the results in American Indians remain statistically insignificant after sensitivity analyses due to their wide 95% CIs including 1, and their p-values > 0.05.
Subgroup and sensitivity analyses for black people
In Black people, subgroup analyses by sex showed men (RR = 0.57, 95% CI = 0.51–0.63, p < 0.0001) had a higher risk of fracture than women (RR = 0.43, 95% CI = 0.39–0.47, p < 0.0001) when compared with their white counterparts. The risk of fracture was greater in studies that reported vertebral fractures (RR = 0.50, 95% CI = 0.36–0.68, p < 0.0001), were cohort in design (RR = 0.45, 95% CI = 0.42–0.48, p < 0.0001), were published before 2011 (RR = 0.46, 95% CI = 0.42–0.51, p <0.0001), and were adjusted for BMD (RR = 0.50, 95% CI = 0.42–0.58, p < 0.0001). However, these subgroup differences were not statistically significant due to overlapping confidence intervals within their own subgroups (Table 6). Substantial heterogeneity (I2 = 75%) was observed between the twenty-two studies. A sensitivity analysis was conducted by omitting one study in each analysis so as to determine its impact on heterogeneity. The study by Amir et al. was the single greatest contributor to the heterogeneity23. By removing this study, heterogeneity was reduced by 11% (I2 = 64%). The study methodology did not differ much compared to the other included studies, although it did contain the second-largest study population of all studies involving all races and ethnicities, and its population was composed strictly of individuals aged ≥ 65 in nursing homes. Regarding the pooled effect sizes, there were no major changes when each study was omitted one at a time.
Subgroup and sensitivity analyses for Hispanics
In Hispanics, subgroup analyses revealed the risk of fracture was greater in cross-sectional studies (RR = 0.74, 95% CI = 0.67–0.81, p < 0.0001), studies published before 2011 (RR = 0.67, 95% CI = 0.50–0.89, p = 0.0063), and studies that adjusted for BMD (RR = 0.89, 95% CI = 0.72–1.10, p = 0.2920). However, these subgroup differences were not statistically significant due to overlapping confidence intervals within their own subgroups (Table 7). Subgroup analyses by sex and fracture site were incomplete due to the lack of studies that reported the risk of fractures in men and the risk of vertebral fractures (Table 7). However, the RR of studies that reported the risk of fractures in women (RR = 0.59, 95% CI = 0.47–0.76, p < 0.0001) and risks of hip fractures (RR = 0.54, 95% CI = 0.38–0.76, p = 0.0006) did not statistically differ from the original association of Hispanic ethnicity with fractures (RR = 0.66, 95% CI = 0.55–0.79, p < 0.0001). There was considerable heterogeneity (I2 = 99%) observed between the studies included in the analysis. Another “one-study removed” sensitivity analysis revealed that the removal of Sullivan et al. moderately reduced heterogeneity (I2 = 66%)10. The study’s methodology did not differ significantly from the other included studies. However, it was the only included study whose entire study population resides in California. The study only controlled for age, while the majority of the other studies controlled for additional variables. The omission of Sullivan et al. changed the pooled effect size because its removal resulted in the relative fracture risk in Hispanics increasing to 0.73 (95% CI, 0.68–0.78)10.
Subgroup and sensitivity analyses for Asian Americans
In Asian Americans, subgroup analyses showed the risk of fracture was higher in women (RR = 0.51, 95% CI = 0.40–0.65, p < 0.0001) and in studies published before 2011 (RR = 0.61, 95% CI = 0.51–0.74, p < 0.0001). Nonetheless, these subgroup differences were not statistically significant due to overlapping 95% CIs within their own subgroups (Table 8). Subgroup analyses by anatomical site of the fracture, study design, and adjustment for BMD were incomplete due to an insufficient number of studies (Table 8). However, the RR of studies that reported the risk of hip fractures (RR = 0.49, 95% CI = 0.35–0.68, p < 0.0001), were cohort studies (RR = 0.54, 95% CI = 0.44–0.67, p < 0.0001), and were not adjusted for BMD (RR = 0.56, 95% CI = 0.46–0.68, p < 0.0001) did not statistically differ from the original association of Asian race with fractures (RR = 0.55, 95% CI = 0.45–0.66, p < 0.0001). A similar considerable heterogeneity (I2 = 99%) was observed in the pooled effect sizes analysis. A sensitivity analysis demonstrated that the removal of Sullivan et al. minimally reduced heterogeneity (I2 = 83%)10. The study’s omission increased the relative risk of fracture in Asian Americans to 0.61 (95% CI, 0.54–0.68). Similar to studies included in the Hispanics analysis, Sullivan et al. was the only study that reported populations limited to California and that only adjusted the effect sizes for age10.
Subgroup and sensitivity analyses for American Indians
In American Indians, there were insufficient studies to properly conduct subgroup analyses by sex, anatomical site of the fracture, study design, year of publication, and adjustment for BMD (Table 9). In addition, none of the RR in the available subgroups statistically differed from the original association of the American Indian race with fractures (RR = 0.80, 95% CI = 0.41–1.58, p = 0.3436). In the pooled effect size analysis, there was also considerable heterogeneity (I2 = 99%). As in the previous groups, a sensitivity analysis was performed and determined the removal of Sullivan et al. completely removed heterogeneity (I2 = 0%)10. By omitting the study, fracture risk increased to 1.05 (95% CI, 0.98–1.14). Differences in study methodology between Sullivan et al. and the other included studies are similar to those observed in the other analyses10.
Publication bias
Funnel plots and the Egger tests were performed to assess publication bias for Black people and Hispanics. We could not examine publication bias for Asian Americans and American Indians due to an insufficient number of studies (< 10). The funnel plots (Fig. 3) and Egger tests suggested there was no significant publication bias in Black people (p = 0.42); however, publication bias was detected in Hispanics (p = 0.036).
Discussion
Our comprehensive meta-analysis of available observational studies examined the association between race and ethnicity and fracture risk. That analysis showed that people of racial-ethnic minority groups were at a lower fracture risk than white people. Compared with white people, the relative fracture risk decreased by 54% in Black people, 34% in Hispanics, 45% in Asian Americans, and 20% in American Indians.
Our study findings are consistent with previous literature reviews regarding the risk of fractures in different races and ethnicities18,19. However, there have not yet been any published systematic reviews or meta-analyses, and thus no quantitative data on the association between race and ethnicity and the risk of fractures. In the present study, we performed meta-analyses for each race group and included subgroup analyses and sensitivity analyses to further examine the robustness of our findings. In addition, while previous reviews explored data from countries outside the US, we focused strictly on studies conducted in the US population. Moreover, the previous reviews were published nearly a decade ago and could not integrate findings from recently published extensive studies20,21,22,23,24.
The role that race plays in clinical decisions has been an increasing point of discussion in recent years. In the context of osteoporotic fractures, a recent study by Vyas et al. has questioned the use of race in FRAX USA’s calculation of the 10-year probability of fractures17. However, the current study cements the idea of race and ethnicity as a clinical risk factor for fractures, similar to any other risk factors. While this supports the use of race adjustments in FRAX USA, it is important to consider patient demographics and other clinical risk factors when discussing predictions of fractures. Together, these factors can help properly identify individuals at high risk of fractures, guide clinicians to treat the appropriate patients, and help close the osteoporosis treatment gap44. Although the underlying difference in risk factors between separate race groups is not yet fully understood, several risk factors have been heavily implicated in the risk of osteoporosis and fractures. While risk factors such as smoking, alcohol consumption, and Type 1 diabetes have been shown to increase the risk of fractures, low BMD continues to be one of the strongest predictors of future fractures45,46,47. In Black people, subgroup analysis by studies that controlled for BMD revealed the association between race and fracture risk continued to be significant even after adjusting for BMD. However, a similar conclusion cannot be made for the other races and ethnicities due to statistically insignificant results or a limited number of studies that adjusted for BMD. A fact is that for every standard deviation decrease in femur neck BMD (FNBMD), the risk of hip fractures increases by 294% in men and 288% in women at the age of 6548. Previous studies have continuously reported higher BMD in Black people in comparison with the other races and ethnicities21,22,24. Black people also exhibit a decreased age-adjusted annual decline in BMD49. The overall higher BMD at all sites and lower BMD loss as Black people age may help explain their significantly lower risk of fractures. Another explanation that may influence the measured difference between the risk of fractures in Black and white people is the difference in life expectancy at birth between the two races. In the US, Black people have a life expectancy at birth of 72 years, whereas white people have a life expectancy of 78 years50. As osteoporosis and resulting fractures are most common in the elderly population, with higher age groups at increasing risk, differences in life expectancy can influence the availability of Black participants in observational studies, thus, underestimating the rates and risks of fractures. Examining data from other countries with diverse but distinct racial and ethnic groups revealed similarities in the risks and rates of fractures between white and Black populations. For example, in South Africa, the African population was observed to possess the lowest incidence rates of fractures. The white population had the highest incidence rates, while the other races and ethnic groups were between white people and Africans51. These observed differences show similarity to the situation in the US. Consequently, the latest version of FRAX incorporated a South African-specific model in which race adjustments are performed in the tool’s output.
In Hispanics, FNBMD measurements are higher than in white people but lower than in Black people. In NHANES 2005–2006, FNBMD was 6.6% greater in Mexican American women than in white women, while FNBMD in Black women was 10% greater than in white women52. MrOS demonstrated FNBMD was 2% higher in Hispanic men than in white men53. Interestingly, several large studies have shown lumbar spine BMD (LSBMD) in Hispanics to be lower than in white people54,55,56. Unfortunately, we were unable to explore how this translates into vertebral fracture risks due to the limited number of studies reporting vertebral fractures in Hispanics. In American Indians, data regarding BMD measurements have been scarce. While our meta-analysis showed American Indians were at a decreased risk of fractures compared to white people, the wide confidence interval suggests no statistically significant difference in fracture risk between the two races. Data from the WHI study and the National Osteoporosis Risk Assessment study showed American Indian women possess similar BMD at various sites in comparison to white women23,57. In contrast to the relation between BMD and fracture risk observed in the other races, Asian Americans possess lower BMD than white people, yet are at a decreased risk of fractures. There have been various attempts to address this paradox. One explanation contributes to the lower risk of fractures in Asian Americans to their skeletal geometry, whereby Asian Americans tend to have a shorter hip axis length58,59. Since longer hip axis length has been associated with an increased risk of fractures, the shorter hip axis length in Asian Americans may confer protection against hip fractures60,61. Another explanation proposes studies that reported areal BMD (aBMD) did not adjust for weight, height, and other important covariates. An example of this was seen in the Study of Women’s Health Across the Nation. Compared with Black and white women, Asian American women seemed to possess the lowest unadjusted lumbar vertebrae and femoral neck aBMD62. However, after adjusting for weight and other covariates, aBMD was greater in Asian American women than in white women. Similarly, a study on men from four countries found that the aBMD gap between white people and Asians was significantly reduced after adjusting for height and weight54.
Although these factors could help explain the racial and ethnic differences in fracture risks, it must be noted that many of these factors, such as aBMD, were not adjusted in the analyses of the included studies. As seen from the subgroup analyses, most included studies did not adjust for BMD. Only 3 of 21 studies in Black people and 2 of 11 studies in Hispanics adjusted for BMD, while no studies in Asian Americans and American Indians adjusted for BMD20,33,34,35. Furthermore, other well-established risk factors for fractures known to differ between races and ethnicities, such as volumetric BMD (vBMD) or failure load, have not been included as a confounder in the included studies’ analyses63,64. There are also socio-demographic and socioeconomic determinants of fracture risks, such as education and income. For example, an inverse relationship between fracture risk and income was observed in Medicare beneficiaries65. In our included studies, only 4 of 22 studies adjusted for education, and only one adjusted for family income20,31,35,37. These clinical, socio-demographic, and socioeconomic factors all play an important role in the risks of fractures. They should be considered when discussing the fracture risks between races and ethnicities. Future studies should explore these factors further in-depth to help explain the observed variations in risks and rates of fracture among different races and ethnicities.
While our findings suggest that a focus should be placed on white people and perhaps American Indians, it is crucial to understand that the number of fractures and associated costs is expected to balloon over the coming years due to shifting demographics in the US. While this can be attributed to an overall aging population, we must also consider that population growth in minority races exceeds that of white people14. Thus, the significance of proper bone health should not be neglected for all population groups. Healthcare disparities exist in all stages of care, from screening to post-fracture outcomes. In studies of Black women, they were less likely than their white counterparts to be referred for dual-energy x-ray absorptiometry (DXA) screening, to know their DXA results, and to be properly prescribed osteoporosis medication11,66,67. In a large study of Medicare patients with hip fractures, Black and Hispanic women were 48% and 34%, respectively, less likely than white women to have undergone bone testing prior to their fractures68. However, data regarding screening rates in races and ethnicities other than Black have been scarce and mixed, making it harder to draw conclusions69, which demonstrates the need for more research on the disparities in the screening and treatment of minority groups. With regards to post-fracture care, outcomes similarly differ by race and ethnicity. After suffering common osteoporotic fractures, such as hip or vertebral fractures, the risk of mortality is not the same in every race. In a study of US Medicare data from 2010 to 2016, Black women suffered greater rates of mortality, frailty, and poverty after a fracture when compared to white women70. In another large study of three cohorts, white people were 1.74 more likely to survive six months post-fracture than other races and ethnic groups, including Black people and Hispanics7. The reasons for these discrepancies are not yet fully understood. The current research adds to the pool of knowledge that physicians and other healthcare providers can use when assessing fracture risk in patients of different races. Our research is, to our knowledge, the first study that provides quantitative evidence regarding the association between race and ethnicity and the risk of fractures. However, as evidenced by the discrepancy in the number of studies that reported results for Black people and other races and ethnicities, there is an obvious need for more research into Hispanics, Asian Americans, and American Indians. In addition to including more participants of these races and ethnicities, future research should also attempt to adjust for both age and BMD, as these are important risk factors for developing osteoporosis and subsequent fractures. Lastly, there is an urgent need for more research into sociological factors influencing socioeconomic and socio-demographic characteristics of different racial and ethnic minority groups and how these interplay with the risk of osteoporosis and osteoporotic fractures, which is essential in reducing the observed healthcare disparities across different racial and ethnic groups.
Our study has several limitations. First, there was substantial to considerable heterogeneity in all of the analyses. In three of four analyses, it may be possible to attribute this to the nature of I2. When the number of studies pooled together is small, there is a tendency for I2 to introduce significant bias71, which may partially explain the heterogeneity observed in the Hispanic, Asian American, and American Indian analyses (I2 = 99%). Another explanation of heterogeneity may be pooling cross-sectional studies with other study designs. Although cross-sectional studies are less expensive and more convenient to perform than case-control or cohort studies, they are often more susceptible to bias, such as non-response and recall bias72. Subgroup analyses by study design were performed to ensure the pooling of different study designs did not significantly influence our findings. In the subgroup analyses by study design for Black people and Hispanics, no significant differences in effect sizes were observed when comparing cross-sectional and cohort studies. In Asian Americans and American Indians, subgroup analyses were not performed due to the limited studies available. Another explanation could be due to the inherent nature of pooling observational studies. Oftentimes in such meta-analyses, it is difficult to control for the baseline characteristics of participants across the included studies, especially given the number of variables that can influence the risk of osteoporotic fractures. Second, our meta-analyses pooled several measures of effect sizes together (OR, RR, and HR). As previously mentioned, OR is often interpreted as broadly equivalent to RR due to the rare nature of fractures24. In contrast, HR differs from RR because it considers the timing of the outcome. Nonetheless, HR has been deemed broadly equivalent to RR, and pooling the two is common in meta-analysis research73,74,75,76. To ensure the addition of HR did not affect our results, we performed a sensitivity analysis by including only studies that reported effect sizes using HR. In analyses where sufficient studies were available, the exclusion of RR/OR did not considerably affect our findings, which remained significant. Third, it is important to consider socio-demographic, socioeconomic, and other clinical risk factors when discussing fracture risks in different races and ethnicities. In our meta-analysis, most included studies did not account for many of these established confounders known to influence fracture risks. Finally, our research focused on race and ethnic groups within the US only and thus may not be generalizable to other countries. Furthermore, it should also be taken into consideration that race and ethnic groups in the US are comprised of individuals with ancestry from different countries with varying fracture rates. This may translate into differing risks of fractures for individuals within the same race and ethnic group and is why patient demographics and other clinical risk factors, along with race and ethnicity should be considered when identifying patients at high risk of fractures.
Conclusion
Our study showed that people of other races and ethnicities in the US are at a lower risk of fracture than white people. This decrease in risk was most significant in Black people and least significant in American Indians; a moderate decrease in risk was observed in Hispanics and Asian Americans. Our findings add to the tools available for healthcare providers who screen, diagnose, and treat men and women at risk of fractures. The work we have done provides quantitative data regarding fracture risk across different racial and ethnic groups, which along with patients’ clinical information, helps identify those who would benefit most from the initiation of osteoporosis treatment and help close the osteoporosis treatment gap. Our work also demonstrates the need for further research into fracture risks and their contributors. There are substantial gaps in osteoporosis research, especially in Hispanic, Asian American, and American Indian populations, and the currently available research clearly demonstrates the presence of healthcare disparities in minority populations.
Methods
This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines77,78. The protocol of this review was prospectively registered on PROSPERO (CRD42021239943).
Search strategy and data sources
A comprehensive search of PubMed and EMBASE electronic databases was performed to include studies from the databases’ date of inception to October 20, 2021. An updated literature search was conducted on December 23, 2022. The search strategy for each database is reported in Supplemental Table S1 and S2. References from relevant studies were also searched to identify other potentially eligible studies. For this meta-analysis and review, studies were limited to those published in English.
The following search terms were used to identify studies: “fractures,” “blacks,” “African American,” “whites,” “Caucasian,” “Hispanic,” “Latino,” “Asian,” “Native American,” “American Indian,” “Alaska Native,” “Pacific Islander,” “Native Hawaiian.”
Study selection
In the initial study selection stage, investigators Y.B. and Z.L. independently screened each article’s title and abstract from the electronic literature search for studies that investigated the association between race and ethnicity and the risk of fractures. The following criteria were used to screen for relevance: (1) the study population was limited to the US, (2) the study reported the effect size of racial-ethnic minority groups using white people as the reference group, and (3) the study reported fractures as the outcome. We defined fractures as those occurring in any site. However, fractures attributed to major trauma were excluded. Citations deemed irrelevant by both investigators were excluded, and articles with disagreements at the screening were included for a full review in the second study selection stage. There are no clinical trial studies that meet the inclusion criteria.
In the second study selection stage, the full text of each article obtained during the initial study selection stage was reviewed and evaluated for inclusion. Studies had to be cohort, cross-sectional, or case-control in design, had to report outcomes using odds ratio (OR), relative risk (RR), or hazard ratio (HR), and had to include the corresponding 95% confidence intervals (CI). Studies were also included if the effect sizes were calculable from the provided data. Disagreements between investigators were resolved through discussion, and if necessary, a third investigator (Y.X.) was consulted. Agreement between investigators was evaluated using the κ statistic, a robust measure of inter-rater reliability.
Data extraction and study appraisal
Investigators Y.B. and Z.L. performed data extraction independently. The following information was extracted from each study: study characteristics (title, name of first author, year of publication, journal, duration of follow-up in cohort studies, number of cases and controls in case-control studies, total number of study participants), participants’ characteristics (age, sex, and race and ethnicity), outcomes and ascertainment of outcomes, and risk estimates (adjusted RR, OR, and HR and 95% CI). For cases of missing or unclear data, study authors were contacted for clarification and/or additional data. In our systematic review and meta-analysis, we refer to the biological sex when referring to men and women. Race and ethnicity are in accordance with the United States Census Bureau, whereby white people, Black people, Asian Americans, and American Indians are race categories and Hispanic ethnicity. The methodological quality of both the case-control and cohort studies was assessed using the Newcastle-Ottawa Scale (NOS)79. For cross-sectional studies, a modified NOS was used. In accordance with MOOSE guidelines, quality scores were not used as weights in the analyses. Instead, they were used in the sensitivity analysis, where studies with low scores were excluded. A study was considered high-quality if it scored ≥ 7 on the NOS, while a low-quality study scored < 7.
Statistical analysis
In our meta-analysis, RR was used to measure the association between race and ethnicity and the risk of fracture. We calculated the pooled effect size using OR, RR, and HR and the 95% CIs reported by the included studies. Due to the occurrence of fractures being rare, we approximated ORs as RRs80. When determining the weights of the studies, the inverse-variance method was used.
Between-study heterogeneity was measured using the Higgins I2 index, which measures how much of the variability in the effects is due to heterogeneity instead of chance alone81. We interpreted I2 < 40% as minimal heterogeneity, 30–60% as moderate heterogeneity, 50–90% as substantial heterogeneity, and > 75% as considerable heterogeneity82,83. In light of the heterogeneity, the DerSimonian and Laird random-effects model was used to pool the overall effect sizes84.
Sensitivity analyses were performed to assess the robustness of our findings. We examined the influence of race and ethnicity by fracture definition, adjustment for age and other fracture risk factors, stratification by age (age ≥ 65 vs. < 65), methodological quality score, and type of effect size. Pre-specific subgroup analyses were also conducted to determine if study demographics influenced the effects of race and ethnicity on the risk of fractures. The subgroup analysis variables were sex (men vs. women), anatomical site of fracture (hip vs. vertebrae), study design (case-control, cross-sectional, or cohort), year of publication (pre-2011 vs. post-2011), and adjustment for BMD.
Potential publication bias was examined by constructing a funnel plot that plotted RRs against their standard errors85. The Egger’s test was also conducted to help assess the presence of publication bias in the funnel plots86. For races and ethnicities with less than ten studies, a funnel plot was not performed because its ability to detect publication bias through asymmetry is too unreliable87,88.
All data analyses were conducted using the R statistical software (Version 4.0, Core Team, Vienna, Austria). A p-value of 0.05 or less was considered to be statistically significant.
Data availability
All data generated or analyzed during this study are included in this published article.
References
Lewiecki, E. M. et al. Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017. Osteoporos. Int. 31, 1299–1304. https://doi.org/10.1007/s00198-020-05334-y (2020).
Burge, R. et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J. Bone Miner. Res. 22, 465–475. https://doi.org/10.1359/jbmr.061113 (2007).
Sarafrazi, N., Wambogo, E. A. & Shepherd, J. A. Osteoporosis or low bone mass in older adults: United States, 2017–2018. NCHS Data Brief. 1–8 (2021).
Nazrun, A. S., Tzar, M. N., Mokhtar, S. A. & Mohamed, I. N. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: Morbidity, subsequent fractures, and mortality. Ther. Clin. Risk Manag. 10, 937–948. https://doi.org/10.2147/TCRM.S72456 (2014).
Teng, G. G., Curtis, J. R. & Saag, K. G. Mortality and osteoporotic fractures: Is the link causal, and is it modifiable?. Clin. Exp. Rheumatol. 26, S125-137 (2008).
Bliuc, D. et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301, 513–521. https://doi.org/10.1001/jama.2009.50 (2009).
Penrod, J. D. et al. The association of race, gender, and comorbidity with mortality and function after hip fracture. J. Gerontol. A. Biol. Sci. Med. Sci. 63, 867–872. https://doi.org/10.1093/gerona/63.8.867 (2008).
Graham, J. E., Chang, P. F., Berges, I. M., Granger, C. V. & Ottenbacher, K. J. Race/ethnicity and outcomes following inpatient rehabilitation for hip fracture. J. Gerontol. A. Biol. Sci. Med. Sci. 63, 860–866. https://doi.org/10.1093/gerona/63.8.860 (2008).
Brauer, C. A., Coca-Perraillon, M., Cutler, D. M. & Rosen, A. B. Incidence and mortality of hip fractures in the United States. JAMA 302, 1573–1579. https://doi.org/10.1001/jama.2009.1462 (2009).
Sullivan, K. J., Husak, L. E., Altebarmakian, M. & Brox, W. T. Demographic factors in hip fracture incidence and mortality rates in California, 2000–2011. J. Orthop. Surg. Res. 11, 4. https://doi.org/10.1186/s13018-015-0332-3 (2016).
Hamrick, I., Cao, Q., Agbafe-Mosley, D. & Cummings, D. M. Osteoporosis healthcare disparities in postmenopausal women. J. Womens. Health (Larchmt) 21, 1232–1236. https://doi.org/10.1089/jwh.2012.3812 (2012).
Curtis, J. R. et al. Longitudinal trends in use of bone mass measurement among older americans, 1999–2005. J. Bone Miner. Res. 23, 1061–1067. https://doi.org/10.1359/jbmr.080232 (2008).
Cheng, H. et al. Estimated prevalence and patterns of presumed osteoporosis among older Americans based on medicare data. Osteoporos. Int. 20, 1507–1515. https://doi.org/10.1007/s00198-009-0835-z (2009).
Vespa J, Medina L & Armstrong DM. (ed U.S. Census Bureau) 25–1144 (2020).
Yearby, R. race based medicine, colorblind disease: How racism in medicine harms us all. Am. J. Bioeth. 21, 19–27. https://doi.org/10.1080/15265161.2020.1851811 (2021).
Borrell, L. N. et al. Race and genetic ancestry in medicine—a time for reckoning with racism. N .Engl. J. Med. 384, 474–480. https://doi.org/10.1056/NEJMms2029562 (2021).
Vyas, D. A., Eisenstein, L. G. & Jones, D. S. Hidden in plain sight—reconsidering the use of race correction in clinical algorithms. N. Engl. J. Med. 383, 874–882. https://doi.org/10.1056/NEJMms2004740 (2020).
Cauley, J. A. Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin. Orthop. Relat. Res. 469, 1891–1899. https://doi.org/10.1007/s11999-011-1863-5 (2011).
Sterling, R. S. Gender and race/ethnicity differences in hip fracture incidence, morbidity, mortality, and function. Clin. Orthop. Relat. Res. 469, 1913–1918. https://doi.org/10.1007/s11999-010-1736-3 (2011).
Looker, A. C. Femur neck bone mineral density and fracture risk by age, sex, and race or Hispanic origin in older US adults from NHANES III. Arch. Osteoporos. 8, 141. https://doi.org/10.1007/s11657-013-0141-4 (2013).
Chang, P. Y. et al. Prevalence and risk of fracture diagnoses in women across the adult life span: A national cross-sectional study. Osteoporos. Int. 27, 3177–3186. https://doi.org/10.1007/s00198-016-3655-y (2016).
Berry, S. D. et al. Incidence of hip fracture in U.S. nursing homes. J. Gerontol. A Biol. Sci. Med. Sci. 71, 1230–1234. https://doi.org/10.1093/gerona/glw034 (2016).
Amir, O., Berry, S. D., Zullo, A. R., Kiel, D. P. & Zhang, T. Incidence of hip fracture in Native American residents of U.S. nursing homes. Bone 123, 204–210. https://doi.org/10.1016/j.bone.2019.04.001 (2019).
Yusuf, A. A., Hu, Y., Chandler, D., Crittenden, D. B. & Barron, R. L. Predictors of imminent risk of fracture in medicare-enrolled men and women. Arch. Osteoporos. 15, 120. https://doi.org/10.1007/s11657-020-00784-7 (2020).
Griffin, M. R., Ray, W. A., Fought, R. L. & Melton, L. J. 3rd. Black-white differences in fracture rates. Am. J. Epidemiol. 136, 1378–1385. https://doi.org/10.1093/oxfordjournals.aje.a116450 (1992).
Baron, J. A. et al. Racial differences in fracture risk. Epidemiology 5, 42–47. https://doi.org/10.1097/00001648-199401000-00008 (1994).
Ross, P. D. et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int. J. Epidemiol. 24, 1171–1177. https://doi.org/10.1093/ije/24.6.1171 (1995).
Karagas, M. R., Lu-Yao, G. L., Barrett, J. A., Beach, M. L. & Baron, J. A. Heterogeneity of hip fracture: Age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am. J. Epidemiol. 143, 677–682. https://doi.org/10.1093/oxfordjournals.aje.a008800 (1996).
Lauderdale, D. S. et al. Hip fracture incidence among elderly Asian-American populations. Am. J. Epidemiol. 146, 502–509. https://doi.org/10.1093/oxfordjournals.aje.a009304 (1997).
Turner, L. W., Wang, M. Q. & Fu, Q. Risk factors for hip fracture among southern older women. South Med. J. 91, 533–540. https://doi.org/10.1097/00007611-199806000-00005 (1998).
Bohannon, A. D., Hanlon, J. T., Landerman, R. & Gold, D. T. Association of race and other potential risk factors with nonvertebral fractures in community-dwelling elderly women. Am. J. Epidemiol. 149, 1002–1009. https://doi.org/10.1093/oxfordjournals.aje.a009744 (1999).
Young, Y., Myers, A. H. & Provenzano, G. Factors associated with time to first hip fracture. J. Aging Health 13, 511–526. https://doi.org/10.1177/089826430101300404 (2001).
Cauley, J. A. et al. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA 293, 2102–2108. https://doi.org/10.1001/jama.293.17.2102 (2005).
Cauley, J. A. et al. Prevalent vertebral fractures in black women and white women. J. Bone Miner. Res. 23, 1458–1467. https://doi.org/10.1359/jbmr.080411 (2008).
Barrett-Connor, E. et al. Osteoporosis and fracture risk in women of different ethnic groups. J. Bone Miner. Res. 20, 185–194. https://doi.org/10.1359/JBMR.041007 (2005).
Tracy, J. K. et al. Racial differences in the prevalence of vertebral fractures in older men: The Baltimore men’s osteoporosis study. Osteoporos. Int. 17, 99–104. https://doi.org/10.1007/s00198-005-1919-z (2006).
Cauley, J. A. et al. Clinical risk factors for fractures in multi-ethnic women: The women’s health initiative. J. Bone Miner. Res. 22, 1816–1826. https://doi.org/10.1359/jbmr.070713 (2007).
Mackey, D. C. et al. Prediction of clinical non-spine fractures in older black and white men and women with volumetric BMD of the spine and areal BMD of the hip: the health, aging, and body composition study*. J. Bone Miner. Res. 22, 1862–1868. https://doi.org/10.1359/jbmr.070807 (2007).
Bauer, R. L., Diehl, A. K., Barton, S. A., Brender, J. & Deyo, R. A. Risk of postmenopausal hip fracture in Mexican American women. Am. J. Pub. Health 76, 1020–1021. https://doi.org/10.2105/ajph.76.8.1020 (1986).
Bauer, R. L. & Deyo, R. A. Low risk of vertebral fracture in Mexican American women. Arch. Int. Med. 147, 1437–1439 (1987).
Jacobsen, S. J. et al. Hip fracture incidence among the old and very old: A population-based study of 745,435 cases. Am J Pub. Health 80, 871–873. https://doi.org/10.2105/ajph.80.7.871 (1990).
Fisher, E. S. et al. Hip fracture incidence and mortality in New England. Epidemiology 2, 116–122. https://doi.org/10.1097/00001648-199103000-00005 (1991).
Wright, N. C. et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J. Bone Miner. Res. 27, 2325–2332. https://doi.org/10.1002/jbmr.1684 (2012).
Lewiecki, E. M., Wright, N. C. & Singer, A. J. Racial disparities, FRAX, and the care of patients with osteoporosis. Osteoporos. Int. 31, 2069–2071. https://doi.org/10.1007/s00198-020-05655-y (2020).
Kanis, J. A. et al. Smoking and fracture risk: A meta-analysis. Osteoporos. Int 16, 155–162. https://doi.org/10.1007/s00198-004-1640-3 (2005).
Berg, K. M. et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am. J. Med. 121, 406–418. https://doi.org/10.1016/j.amjmed.2007.12.012 (2008).
Shah, V. N., Shah, C. S. & Snell-Bergeon, J. K. Type 1 diabetes and risk of fracture: Meta-analysis and review of the literature. Diabet. Med. 32, 1134–1142. https://doi.org/10.1111/dme.12734 (2015).
Johnell, O. et al. Predictive value of BMD for hip and other fractures. J. Bone Miner. Res. 20, 1185–1194. https://doi.org/10.1359/JBMR.050304 (2005).
Tracy, J. K., Meyer, W. A., Flores, R. H., Wilson, P. D. & Hochberg, M. C. Racial differences in rate of decline in bone mass in older men: The Baltimore men’s osteoporosis study. J. Bone Miner. Res. 20, 1228–1234. https://doi.org/10.1359/JBMR.050310 (2005).
Arias E, Tejada-Vera B, Ahmad F. Provisional life expectancy estimates for January through June, 2020. Vital statistics rapid release; no 10. Hyattsville, MD: National Center for Health Statistics, February (2021)
Dela, S. S. et al. Ethnic and gender-specific incidence rates for hip fractures in South Africa: A multi-centre study. Bone 133, 115253, doi:https://doi.org/10.1016/j.bone.2020.115253 (2020).
Looker, A. C., Melton, L. J. 3rd., Harris, T. B., Borrud, L. G. & Shepherd, J. A. Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J. Bone Miner. Res. 25, 64–71. https://doi.org/10.1359/jbmr.090706 (2010).
Marshall, L. M. et al. Race and ethnic variation in proximal femur structure and BMD among older men. J. Bone Miner. Res. 23, 121–130. https://doi.org/10.1359/jbmr.070908 (2008).
Nam, H. S. et al. Race/ethnic differences in bone mineral densities in older men. Osteoporos. Int. 21, 2115–2123. https://doi.org/10.1007/s00198-010-1188-3 (2010).
Berenson, A. B., Rahman, M. & Wilkinson, G. Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos. Int. 20, 1439–1449. https://doi.org/10.1007/s00198-008-0817-6 (2009).
Morton, D. J., Barrett-Connor, E., Kritz-Silverstein, D., Wingard, D. L. & Schneider, D. L. Bone mineral density in postmenopausal Caucasian, Filipina, and Hispanic women. Int. J. Epidemiol. 32, 150–156. https://doi.org/10.1093/ije/dyg024 (2003).
Wampler, N. S. et al. Bone mineral density of American Indian and Alaska Native women compared with non-Hispanic white women: Results from the women’s health initiative study. Menopause 12, 536–544. https://doi.org/10.1097/01.gme.0000182161.88939.f0 (2005).
Cummings, S. R. et al. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of osteoporotic fractures research group. Osteoporos. Int. 4, 226–229. https://doi.org/10.1007/BF01623243 (1994).
Cong, E. & Walker, M. D. The Chinese skeleton: Insights into microstructure that help to explain the epidemiology of fracture. Bone Res. 2, 14009. https://doi.org/10.1038/boneres.2014.9 (2014).
Leslie, W. D. et al. Hip axis length is a FRAX- and bone density-independent risk factor for hip fracture in women. J. Clin. Endocrinol. Metab. 100, 2063–2070. https://doi.org/10.1210/jc.2014-4390 (2015).
Lee, D. H. et al. Femoral geometry, bone mineral density, and the risk of hip fracture in premenopausal women: A case control study. BMC Musculoskelet. Disord. 17, 42. https://doi.org/10.1186/s12891-016-0893-2 (2016).
Finkelstein, J. S. et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: Effects of anthropometric and lifestyle factors. J. Clin. Endocrinol. Metab. 87, 3057–3067. https://doi.org/10.1210/jcem.87.7.8654 (2002).
Langsetmo, L. et al. Volumetric bone mineral density and failure load of distal limbs predict incident clinical fracture independent HR-pQCT BMD and failure load predicts incident clinical fracture of FRAX and clinical risk factors among older men. J. Bone Miner. Res. 33, 1302–1311. https://doi.org/10.1002/jbmr.3433 (2018).
Chalhoub, D. et al. Areal and volumetric bone mineral density and risk of multiple types of fracture in older men. Bone 92, 100–106. https://doi.org/10.1016/j.bone.2016.08.014 (2016).
Taylor, A. J. et al. Clinical and demographic factors associated with fractures among older Americans. Osteoporos. Int. 22, 1263–1274. https://doi.org/10.1007/s00198-010-1300-8 (2011).
Gillespie, C. W. & Morin, P. E. Trends and disparities in osteoporosis screening among women in the united states, 2008–2014. Am. J. Med. 130, 306–316. https://doi.org/10.1016/j.amjmed.2016.10.018 (2017).
Cram, P. et al. Racial differences and disparities in osteoporosis-related bone health: Results from the PAADRN randomized controlled trial. Med. Care. 55, 561–568. https://doi.org/10.1097/MLR.0000000000000718 (2017).
Neuner, J. M., Zhang, X., Sparapani, R., Laud, P. W. & Nattinger, A. B. Racial and socioeconomic disparities in bone density testing before and after hip fracture. J. Gen. Intern. Med. 22, 1239–1245. https://doi.org/10.1007/s11606-007-0217-1 (2007).
Noel, S. E., Santos, M. P. & Wright, N. C. Racial and ethnic disparities in bone health and outcomes in the United States. J. Bone Miner. Res. 36, 1881–1905. https://doi.org/10.1002/jbmr.4417 (2021).
Wright, N. C. et al. Racial disparities exist in outcomes after major fragility fractures. J. Am. Geriatr. Soc. 68, 1803–1810. https://doi.org/10.1111/jgs.16455 (2020).
von Hippel, P. T. The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med. Res. Methodol. 15, 35. https://doi.org/10.1186/s12874-015-0024-z (2015).
Wang, X. & Cheng, Z. Cross-sectional studies: Strengths, weaknesses, and recommendations. Chest 158, S65–S71. https://doi.org/10.1016/j.chest.2020.03.012 (2020).
A glossary of EBM terms, <https://bestpractice.bmj.com/info/us/toolkit/ebm-tools/a-glossary-of-ebm-terms/>
Barone, B. B. et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300, 2754–2764. https://doi.org/10.1001/jama.2008.824 (2008).
Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 387, 957–967. https://doi.org/10.1016/S0140-6736(15)01225-8 (2016).
Seidelmann, S. B. et al. Dietary carbohydrate intake and mortality: A prospective cohort study and meta-analysis. Lancet Pub. Health 3, e419–e428. https://doi.org/10.1016/S2468-2667(18)30135-X (2018).
Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, n71. https://doi.org/10.1136/bmj.n71 (2021).
Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283, 2008–2012. https://doi.org/10.1001/jama.283.15.2008 (2000).
GA Wells, B. S., D O'Connell, J Peterson, V Wewlch, M Losos, P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, <http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp> (2019).
Zhang, J. & Yu, K. F. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280, 1690–1691. https://doi.org/10.1001/jama.280.19.1690 (1998).
Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557–560. https://doi.org/10.1136/bmj.327.7414.557 (2003).
Deeks, J. J., Higgins, J. P. & Altman, D. G. in Cochrane Handbook for Systematic Reviews of Interventions 241–284 (2019).
Guyatt, G. H. et al. GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J. Clin. Epidemiol. 64, 1294–1302. https://doi.org/10.1016/j.jclinepi.2011.03.017 (2011).
DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177–188. https://doi.org/10.1016/0197-2456(86)90046-2 (1986).
Sterne, J. A., Gavaghan, D. & Egger, M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J. Clin. Epidemiol. 53, 1119–1129. https://doi.org/10.1016/s0895-4356(00)00242-0 (2000).
Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634. https://doi.org/10.1136/bmj.315.7109.629 (1997).
Macaskill, P., Walter, S. D. & Irwig, L. A comparison of methods to detect publication bias in meta-analysis. Stat. Med. 20, 641–654. https://doi.org/10.1002/sim.698 (2001).
Lau, J., Ioannidis, J. P., Terrin, N., Schmid, C. H. & Olkin, I. The case of the misleading funnel plot. BMJ 333, 597–600. https://doi.org/10.1136/bmj.333.7568.597 (2006).
Funding
The research and analysis described in the current publication were partially supported by a grant from the National Institute on Minority Health and Health Disparities (R21MD013681).
Author information
Authors and Affiliations
Contributions
Conceptualization, Y.B, Q.W.; methodology, Y.B., Z.L, and Q.W.; software, Y.B.; validation, Y.B. and Q.W.; formal analysis, Y.B; investigation, Z.L and Y.X.; resources, Q.W.; data curation, Y.B.; writing—original draft preparation, Y.B.; writing—review and editing, Y.B, Y.X. and Q.W.; visualization, Y.B.; supervision, Q.W.; project administration, Y.X. and Q.W.; All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
Yueyang Bao, Yingke Xu, Zhuowei Li, and Qing Wu declare no conflict of interest in this study.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bao, Y., Xu, Y., Li, Z. et al. Racial and ethnic difference in the risk of fractures in the United States: a systematic review and meta-analysis. Sci Rep 13, 9481 (2023). https://doi.org/10.1038/s41598-023-32776-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-32776-1
This article is cited by
-
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures
Aging Clinical and Experimental Research (2024)
-
Disparities in Osteoporosis Prevention and Care: Understanding Gender, Racial, and Ethnic Dynamics
Current Reviews in Musculoskeletal Medicine (2024)
-
Race and ethnic differences in physical activity, osteopenia, and osteoporosis: results from NHANES 2009–2010, 2013–2014, 2017–2018
Archives of Osteoporosis (2023)
-
Demystifying the Risk Factors and Preventive Measures for Osteoporosis
Indian Journal of Orthopaedics (2023)